Latest Health stories from Life.
David Morens, an adviser to Dr. Anthony Fauci, faces indictment for allegedly concealing emails and evading records requests, linked to inquiries about the origins of COVID-19.
The Supreme Court is set to hear arguments regarding skinny labeling, a practice that may affect the accessibility of generic medications in the market.
Recent discussions highlight advancements in obesity medications and the effectiveness of clinical trials in the U.K.
A recent discussion with Google's clinical director sheds light on the significant challenges facing AI applications in healthcare, including updates on Doctronic's Utah experiment.
Industry leaders express significant worries regarding the implications of Trump's drug pricing plan, while Purdue Pharma's sentencing underscores persistent challenges in the pharmaceutical sector.
As the AI revolution unfolds, its implications for patients, clinicians, and health care leaders are becoming increasingly significant. Experts weigh in on the potential impacts.
Experts argue that neglecting mental illness in conversations about brain health limits our understanding and potential for improvement in this critical area.
A new KFF tracker reveals significant federal policy actions related to mental health and substance use during President Trump’s second term.
A recent recommendation to limit hepatitis B vaccinations at birth to only those infants deemed at risk raises alarms about potential increases in infections among newborns.
A new research initiative is monitoring changes in state abortion laws and related legal actions since the Supreme Court's decision to overturn Roe v. Wade.
Erasca has reported that its experimental treatment for pancreatic and lung cancers has delivered results that exceed initial expectations in early trials.
An interactive map illustrates the rise in states implementing laws that limit abortion coverage in Medicaid and private insurance since 2010, highlighting significant policy shifts.
Robert F. Kennedy Jr. has reportedly failed to provide answers to Democrats' inquiries, particularly regarding a controversial contract, leading to increased frustrations.
The Trump administration has expressed concerns regarding the use of federal funds for fentanyl test strips, indicating a shift away from harm reduction strategies.
Archelle Georgiou, a former insider at a major health insurer, discusses the objectives behind prior authorization processes in healthcare.
The House Appropriations Committee has released the FY 2027 National Security, Department of State and Related Programs Appropriations Bill, focusing on global health funding.
Astellas is moving forward with its XLMTM gene therapy trials despite earlier reports of deaths. Meanwhile, Veradermics celebrates success in its hair loss pill trial, and the FDA accelerates reviews for psychedelics.
Recent trial results indicate that a single dose of Intellia's CRISPR treatment can significantly reduce swelling attacks in patients with hereditary angioedema, raising interest in one-time therapies.
As GLP-1 medications become more common for weight management, concerns about their effects on eating behaviors are emerging. Ongoing research aims to clarify these risks.
Veradermics has reported positive results from its late-stage trial for a new hair loss drug, positioning itself as a leading contender in a rapidly growing market.